Australia markets closed

AEON Biopharma, Inc. (AEON)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
1.3900+0.0300 (+2.21%)
At close: 04:00PM EDT
1.4900 +0.10 (+7.19%)
After hours: 07:38PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
-
-
0
0
2,518
3,357
Cost of revenue
-
-
-
-
0
1
Gross profit
-
-
-
-
2,518
3,356
Operating expenses
Research development
-
-
34,754
25,728
7,319
4,814
Selling general and administrative
-
-
13,675
11,153
11,587
46,037
Total operating expenses
-
-
48,429
36,881
18,906
51,726
Operating income or loss
-
-
-48,429
-36,881
-16,388
-48,370
Interest expense
-
-
-
-
15
7,470
Total other income/expenses net
-
-
-4,127
-18,756
-16,510
200,790
Income before tax
-
-
-52,556
-55,637
-32,913
145,670
Income tax expense
-
-
0
0
0
-14,645
Income from continuing operations
-
-
-52,556
-55,637
-32,913
160,315
Net income
-
-
-52,556
-55,637
-32,913
172,920
Net income available to common shareholders
-
-
-52,556
-55,637
-27,444
172,920
Basic EPS
-2.39
-
-2.39
-2.53
-1.85
11.69
Diluted EPS
-2.39
-
-2.39
-2.53
-1.85
11.69
Basic average shares
21,996
37,160
21,996
21,996
14,797
-
Diluted average shares
21,996
37,160
21,996
21,996
14,797
-